Biora Therapeutics, Inc.
Biora Therapeutics, Inc. (BIORQ) Stock Competitors & Peer Comparison
See (BIORQ) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BIORQ | $0.00 | +0.00% | 452 | N/A | N/A | N/A |
| NONOF | $43.80 | -0.64% | 197.7B | 10.45 | $4.26 | +4.05% |
| CSLLY | $17.69 | -0.90% | 68.3B | 11.46 | $1.54 | +4.09% |
| UCBJY | $140.35 | -0.41% | 53.4B | 29.95 | $4.68 | +0.60% |
| UCBJF | $270.35 | -4.22% | 51.5B | 29.29 | $9.23 | +0.60% |
| ARGNF | $803.19 | +0.00% | 49.7B | 35.71 | $22.49 | N/A |
| CMXHF | $70.00 | -4.83% | 34.3B | 11.60 | $6.17 | +3.97% |
| IVBXF | $10.34 | +0.39% | 17.9B | 147.71 | $0.07 | N/A |
| WXIBF | $4.18 | +0.00% | 17.3B | 24.59 | $0.17 | N/A |
| WXXWY | $8.29 | -1.78% | 17.1B | 24.32 | $0.34 | N/A |
Stock Comparison
BIORQ vs NONOF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, NONOF has a market cap of 197.7B. Regarding current trading prices, BIORQ is priced at $0.00, while NONOF trades at $43.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas NONOF's P/E ratio is 10.45. In terms of profitability, BIORQ's ROE is +1.22%, compared to NONOF's ROE of +0.66%. Regarding short-term risk, BIORQ is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check NONOF's competition here
BIORQ vs CSLLY Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, CSLLY has a market cap of 68.3B. Regarding current trading prices, BIORQ is priced at $0.00, while CSLLY trades at $17.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CSLLY's P/E ratio is 11.46. In terms of profitability, BIORQ's ROE is +1.22%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, BIORQ is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check CSLLY's competition here
BIORQ vs UCBJY Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, UCBJY has a market cap of 53.4B. Regarding current trading prices, BIORQ is priced at $0.00, while UCBJY trades at $140.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas UCBJY's P/E ratio is 29.95. In terms of profitability, BIORQ's ROE is +1.22%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, BIORQ is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check UCBJY's competition here
BIORQ vs UCBJF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, UCBJF has a market cap of 51.5B. Regarding current trading prices, BIORQ is priced at $0.00, while UCBJF trades at $270.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas UCBJF's P/E ratio is 29.29. In terms of profitability, BIORQ's ROE is +1.22%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, BIORQ is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check UCBJF's competition here
BIORQ vs ARGNF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, ARGNF has a market cap of 49.7B. Regarding current trading prices, BIORQ is priced at $0.00, while ARGNF trades at $803.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ARGNF's P/E ratio is 35.71. In terms of profitability, BIORQ's ROE is +1.22%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, BIORQ and ARGNF have similar daily volatility (0.00).Check ARGNF's competition here
BIORQ vs CMXHF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, CMXHF has a market cap of 34.3B. Regarding current trading prices, BIORQ is priced at $0.00, while CMXHF trades at $70.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CMXHF's P/E ratio is 11.60. In terms of profitability, BIORQ's ROE is +1.22%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, BIORQ is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check CMXHF's competition here
BIORQ vs IVBXF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, IVBXF has a market cap of 17.9B. Regarding current trading prices, BIORQ is priced at $0.00, while IVBXF trades at $10.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas IVBXF's P/E ratio is 147.71. In terms of profitability, BIORQ's ROE is +1.22%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, BIORQ and IVBXF have similar daily volatility (0.00).Check IVBXF's competition here
BIORQ vs WXIBF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, WXIBF has a market cap of 17.3B. Regarding current trading prices, BIORQ is priced at $0.00, while WXIBF trades at $4.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas WXIBF's P/E ratio is 24.59. In terms of profitability, BIORQ's ROE is +1.22%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, BIORQ is less volatile compared to WXIBF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check WXIBF's competition here
BIORQ vs WXXWY Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, WXXWY has a market cap of 17.1B. Regarding current trading prices, BIORQ is priced at $0.00, while WXXWY trades at $8.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas WXXWY's P/E ratio is 24.32. In terms of profitability, BIORQ's ROE is +1.22%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, BIORQ is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check WXXWY's competition here
BIORQ vs GNMSF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, GNMSF has a market cap of 15.8B. Regarding current trading prices, BIORQ is priced at $0.00, while GNMSF trades at $258.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas GNMSF's P/E ratio is 19.63. In terms of profitability, BIORQ's ROE is +1.22%, compared to GNMSF's ROE of +0.21%. Regarding short-term risk, BIORQ and GNMSF have similar daily volatility (0.00).Check GNMSF's competition here
BIORQ vs SBHMY Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, SBHMY has a market cap of 12.7B. Regarding current trading prices, BIORQ is priced at $0.00, while SBHMY trades at $14.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SBHMY's P/E ratio is 37.59. In terms of profitability, BIORQ's ROE is +1.22%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, BIORQ is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check SBHMY's competition here
BIORQ vs SBMFF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, SBMFF has a market cap of 12.4B. Regarding current trading prices, BIORQ is priced at $0.00, while SBMFF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SBMFF's P/E ratio is 23.07. In terms of profitability, BIORQ's ROE is +1.22%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, BIORQ and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here
BIORQ vs AAVXF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, AAVXF has a market cap of 10B. Regarding current trading prices, BIORQ is priced at $0.00, while AAVXF trades at $126.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas AAVXF's P/E ratio is -22.38. In terms of profitability, BIORQ's ROE is +1.22%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, BIORQ and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
BIORQ vs BRRGF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, BIORQ is priced at $0.00, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, BIORQ's ROE is +1.22%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, BIORQ is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check BRRGF's competition here
BIORQ vs ODTC Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, BIORQ is priced at $0.00, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ODTC's P/E ratio is 1.07. In terms of profitability, BIORQ's ROE is +1.22%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, BIORQ and ODTC have similar daily volatility (0.00).Check ODTC's competition here
BIORQ vs AKBLF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, AKBLF has a market cap of 7.8B. Regarding current trading prices, BIORQ is priced at $0.00, while AKBLF trades at $38.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas AKBLF's P/E ratio is 42.74. In terms of profitability, BIORQ's ROE is +1.22%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, BIORQ is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check AKBLF's competition here
BIORQ vs REGMF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, REGMF has a market cap of 6.8B. Regarding current trading prices, BIORQ is priced at $0.00, while REGMF trades at $12.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas REGMF's P/E ratio is 63.42. In terms of profitability, BIORQ's ROE is +1.22%, compared to REGMF's ROE of +0.42%. Regarding short-term risk, BIORQ is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check REGMF's competition here
BIORQ vs TRSBF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, TRSBF has a market cap of 6.4B. Regarding current trading prices, BIORQ is priced at $0.00, while TRSBF trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas TRSBF's P/E ratio is 5.10. In terms of profitability, BIORQ's ROE is +1.22%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, BIORQ and TRSBF have similar daily volatility (0.00).Check TRSBF's competition here
BIORQ vs ABCZF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, BIORQ is priced at $0.00, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, BIORQ and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
BIORQ vs SHJBF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, SHJBF has a market cap of 4.8B. Regarding current trading prices, BIORQ is priced at $0.00, while SHJBF trades at $3.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SHJBF's P/E ratio is -27.92. In terms of profitability, BIORQ's ROE is +1.22%, compared to SHJBF's ROE of -0.11%. Regarding short-term risk, BIORQ is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check SHJBF's competition here
BIORQ vs GNNSF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, GNNSF has a market cap of 3.8B. Regarding current trading prices, BIORQ is priced at $0.00, while GNNSF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas GNNSF's P/E ratio is -6.90. In terms of profitability, BIORQ's ROE is +1.22%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, BIORQ is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check GNNSF's competition here
BIORQ vs ZLDPF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, ZLDPF has a market cap of 3.5B. Regarding current trading prices, BIORQ is priced at $0.00, while ZLDPF trades at $50.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ZLDPF's P/E ratio is 3.51. In terms of profitability, BIORQ's ROE is +1.22%, compared to ZLDPF's ROE of +0.43%. Regarding short-term risk, BIORQ and ZLDPF have similar daily volatility (0.00).Check ZLDPF's competition here
BIORQ vs TLPPF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, TLPPF has a market cap of 3.3B. Regarding current trading prices, BIORQ is priced at $0.00, while TLPPF trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas TLPPF's P/E ratio is -487.50. In terms of profitability, BIORQ's ROE is +1.22%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, BIORQ is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check TLPPF's competition here
BIORQ vs BRCTF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, BIORQ is priced at $0.00, while BRCTF trades at $33.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BRCTF's P/E ratio is 132.08. In terms of profitability, BIORQ's ROE is +1.22%, compared to BRCTF's ROE of +0.10%. Regarding short-term risk, BIORQ is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check BRCTF's competition here
BIORQ vs MPSYF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, BIORQ is priced at $0.00, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, BIORQ's ROE is +1.22%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, BIORQ is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check MPSYF's competition here
BIORQ vs BVNKF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, BIORQ is priced at $0.00, while BVNKF trades at $30.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BVNKF's P/E ratio is 13.14. In terms of profitability, BIORQ's ROE is +1.22%, compared to BVNKF's ROE of +0.09%. Regarding short-term risk, BIORQ is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check BVNKF's competition here
BIORQ vs BVNRY Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, BVNRY has a market cap of 2.4B. Regarding current trading prices, BIORQ is priced at $0.00, while BVNRY trades at $10.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BVNRY's P/E ratio is 13.03. In terms of profitability, BIORQ's ROE is +1.22%, compared to BVNRY's ROE of +0.09%. Regarding short-term risk, BIORQ is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check BVNRY's competition here
BIORQ vs INCPF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, BIORQ is priced at $0.00, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas INCPF's P/E ratio is 25.83. In terms of profitability, BIORQ's ROE is +1.22%, compared to INCPF's ROE of +0.10%. Regarding short-term risk, BIORQ is less volatile compared to INCPF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check INCPF's competition here
BIORQ vs MEOBF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, MEOBF has a market cap of 2.2B. Regarding current trading prices, BIORQ is priced at $0.00, while MEOBF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas MEOBF's P/E ratio is -24.29. In terms of profitability, BIORQ's ROE is +1.22%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, BIORQ and MEOBF have similar daily volatility (0.00).Check MEOBF's competition here
BIORQ vs GENSF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, GENSF has a market cap of 2.1B. Regarding current trading prices, BIORQ is priced at $0.00, while GENSF trades at $31.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas GENSF's P/E ratio is 33.05. In terms of profitability, BIORQ's ROE is +1.22%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, BIORQ is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check GENSF's competition here
BIORQ vs ASPHF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, ASPHF has a market cap of 1.9B. Regarding current trading prices, BIORQ is priced at $0.00, while ASPHF trades at $5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ASPHF's P/E ratio is -9.88. In terms of profitability, BIORQ's ROE is +1.22%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, BIORQ is less volatile compared to ASPHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check ASPHF's competition here
BIORQ vs GLPGF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, BIORQ is priced at $0.00, while GLPGF trades at $28.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas GLPGF's P/E ratio is -3.50. In terms of profitability, BIORQ's ROE is +1.22%, compared to GLPGF's ROE of +0.16%. Regarding short-term risk, BIORQ and GLPGF have similar daily volatility (0.00).Check GLPGF's competition here
BIORQ vs PHMMF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, BIORQ is priced at $0.00, while PHMMF trades at $106.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas PHMMF's P/E ratio is 46.29. In terms of profitability, BIORQ's ROE is +1.22%, compared to PHMMF's ROE of +0.36%. Regarding short-term risk, BIORQ and PHMMF have similar daily volatility (0.00).Check PHMMF's competition here
BIORQ vs ASCLF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, ASCLF has a market cap of 1.8B. Regarding current trading prices, BIORQ is priced at $0.00, while ASCLF trades at $1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ASCLF's P/E ratio is -33.40. In terms of profitability, BIORQ's ROE is +1.22%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, BIORQ is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check ASCLF's competition here
BIORQ vs ONTTF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, ONTTF has a market cap of 1.7B. Regarding current trading prices, BIORQ is priced at $0.00, while ONTTF trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ONTTF's P/E ratio is -8.85. In terms of profitability, BIORQ's ROE is +1.22%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, BIORQ is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check ONTTF's competition here
BIORQ vs CSPHF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, CSPHF has a market cap of 1.6B. Regarding current trading prices, BIORQ is priced at $0.00, while CSPHF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CSPHF's P/E ratio is -20.20. In terms of profitability, BIORQ's ROE is +1.22%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, BIORQ is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check CSPHF's competition here
BIORQ vs BIESF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, BIORQ is priced at $0.00, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BIESF's P/E ratio is -44.44. In terms of profitability, BIORQ's ROE is +1.22%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, BIORQ and BIESF have similar daily volatility (0.00).Check BIESF's competition here
BIORQ vs IDRSF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, IDRSF has a market cap of 1.4B. Regarding current trading prices, BIORQ is priced at $0.00, while IDRSF trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas IDRSF's P/E ratio is -4.39. In terms of profitability, BIORQ's ROE is +1.22%, compared to IDRSF's ROE of +0.19%. Regarding short-term risk, BIORQ is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check IDRSF's competition here
BIORQ vs HBMHF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, BIORQ is priced at $0.00, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas HBMHF's P/E ratio is 13.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to HBMHF's ROE of +0.28%. Regarding short-term risk, BIORQ is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check HBMHF's competition here
BIORQ vs SNBIF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, BIORQ is priced at $0.00, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, BIORQ's ROE is +1.22%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, BIORQ is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check SNBIF's competition here
BIORQ vs MDCLF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, BIORQ is priced at $0.00, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, BIORQ's ROE is +1.22%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, BIORQ and MDCLF have similar daily volatility (0.00).Check MDCLF's competition here
BIORQ vs NURPF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, BIORQ is priced at $0.00, while NURPF trades at $8.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas NURPF's P/E ratio is 52.21. In terms of profitability, BIORQ's ROE is +1.22%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, BIORQ is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check NURPF's competition here
BIORQ vs CSBTF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, CSBTF has a market cap of 975.4M. Regarding current trading prices, BIORQ is priced at $0.00, while CSBTF trades at $24.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CSBTF's P/E ratio is 309.38. In terms of profitability, BIORQ's ROE is +1.22%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, BIORQ and CSBTF have similar daily volatility (0.00).Check CSBTF's competition here
BIORQ vs BTTAY Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, BIORQ is priced at $0.00, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, BIORQ's ROE is +1.22%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, BIORQ is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check BTTAY's competition here
BIORQ vs PHGUF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, PHGUF has a market cap of 904M. Regarding current trading prices, BIORQ is priced at $0.00, while PHGUF trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas PHGUF's P/E ratio is 64.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to PHGUF's ROE of +0.05%. Regarding short-term risk, BIORQ is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check PHGUF's competition here
BIORQ vs PPTDF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, PPTDF has a market cap of 902M. Regarding current trading prices, BIORQ is priced at $0.00, while PPTDF trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas PPTDF's P/E ratio is -39.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to PPTDF's ROE of -0.05%. Regarding short-term risk, BIORQ and PPTDF have similar daily volatility (0.00).Check PPTDF's competition here
BIORQ vs TKBIF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, BIORQ is priced at $0.00, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas TKBIF's P/E ratio is -14.60. In terms of profitability, BIORQ's ROE is +1.22%, compared to TKBIF's ROE of N/A. Regarding short-term risk, BIORQ is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check TKBIF's competition here
BIORQ vs BPMUF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, BPMUF has a market cap of 805.6M. Regarding current trading prices, BIORQ is priced at $0.00, while BPMUF trades at $65.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BPMUF's P/E ratio is 9.14. In terms of profitability, BIORQ's ROE is +1.22%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, BIORQ and BPMUF have similar daily volatility (0.00).Check BPMUF's competition here
BIORQ vs IVEVF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, IVEVF has a market cap of 741.2M. Regarding current trading prices, BIORQ is priced at $0.00, while IVEVF trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas IVEVF's P/E ratio is -2.41. In terms of profitability, BIORQ's ROE is +1.22%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, BIORQ is less volatile compared to IVEVF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check IVEVF's competition here
BIORQ vs SOLTF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, SOLTF has a market cap of 670.9M. Regarding current trading prices, BIORQ is priced at $0.00, while SOLTF trades at $7.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SOLTF's P/E ratio is -8.41. In terms of profitability, BIORQ's ROE is +1.22%, compared to SOLTF's ROE of -0.16%. Regarding short-term risk, BIORQ is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check SOLTF's competition here
BIORQ vs CKDXF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, BIORQ is priced at $0.00, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, BIORQ's ROE is +1.22%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, BIORQ is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check CKDXF's competition here
BIORQ vs INRLF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, INRLF has a market cap of 489.3M. Regarding current trading prices, BIORQ is priced at $0.00, while INRLF trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas INRLF's P/E ratio is -2.77. In terms of profitability, BIORQ's ROE is +1.22%, compared to INRLF's ROE of -1.06%. Regarding short-term risk, BIORQ is less volatile compared to INRLF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check INRLF's competition here
BIORQ vs GNFTF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, GNFTF has a market cap of 474.3M. Regarding current trading prices, BIORQ is priced at $0.00, while GNFTF trades at $9.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas GNFTF's P/E ratio is -4.74. In terms of profitability, BIORQ's ROE is +1.22%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, BIORQ is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check GNFTF's competition here
BIORQ vs RAONF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, BIORQ is priced at $0.00, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas RAONF's P/E ratio is -43.33. In terms of profitability, BIORQ's ROE is +1.22%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, BIORQ is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check RAONF's competition here
BIORQ vs CYDY Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, CYDY has a market cap of 450.8M. Regarding current trading prices, BIORQ is priced at $0.00, while CYDY trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CYDY's P/E ratio is -8.25. In terms of profitability, BIORQ's ROE is +1.22%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, BIORQ is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check CYDY's competition here
BIORQ vs AVCTF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, AVCTF has a market cap of 448.3M. Regarding current trading prices, BIORQ is priced at $0.00, while AVCTF trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas AVCTF's P/E ratio is -8.54. In terms of profitability, BIORQ's ROE is +1.22%, compared to AVCTF's ROE of -29.83%. Regarding short-term risk, BIORQ is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check AVCTF's competition here
BIORQ vs GNFTY Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, BIORQ is priced at $0.00, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, BIORQ's ROE is +1.22%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, BIORQ is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check GNFTY's competition here
BIORQ vs TBGNF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, BIORQ is priced at $0.00, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, BIORQ's ROE is +1.22%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, BIORQ and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
BIORQ vs VBIZF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, VBIZF has a market cap of 427.9M. Regarding current trading prices, BIORQ is priced at $0.00, while VBIZF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas VBIZF's P/E ratio is 20.27. In terms of profitability, BIORQ's ROE is +1.22%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, BIORQ is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check VBIZF's competition here
BIORQ vs NWPHF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, NWPHF has a market cap of 416.1M. Regarding current trading prices, BIORQ is priced at $0.00, while NWPHF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas NWPHF's P/E ratio is -25.97. In terms of profitability, BIORQ's ROE is +1.22%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, BIORQ is less volatile compared to NWPHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check NWPHF's competition here
BIORQ vs PTCHF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, PTCHF has a market cap of 401.6M. Regarding current trading prices, BIORQ is priced at $0.00, while PTCHF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas PTCHF's P/E ratio is -3.59. In terms of profitability, BIORQ's ROE is +1.22%, compared to PTCHF's ROE of -0.32%. Regarding short-term risk, BIORQ is less volatile compared to PTCHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check PTCHF's competition here
BIORQ vs NWBO Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, NWBO has a market cap of 381.4M. Regarding current trading prices, BIORQ is priced at $0.00, while NWBO trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas NWBO's P/E ratio is -7.74. In terms of profitability, BIORQ's ROE is +1.22%, compared to NWBO's ROE of +0.63%. Regarding short-term risk, BIORQ is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check NWBO's competition here
BIORQ vs CLVLF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, CLVLF has a market cap of 343.8M. Regarding current trading prices, BIORQ is priced at $0.00, while CLVLF trades at $6.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CLVLF's P/E ratio is 14.83. In terms of profitability, BIORQ's ROE is +1.22%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, BIORQ is less volatile compared to CLVLF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check CLVLF's competition here
BIORQ vs SPHDF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, SPHDF has a market cap of 337.7M. Regarding current trading prices, BIORQ is priced at $0.00, while SPHDF trades at $23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SPHDF's P/E ratio is -4.82. In terms of profitability, BIORQ's ROE is +1.22%, compared to SPHDF's ROE of +6.85%. Regarding short-term risk, BIORQ is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check SPHDF's competition here
BIORQ vs CLVLY Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, CLVLY has a market cap of 322.6M. Regarding current trading prices, BIORQ is priced at $0.00, while CLVLY trades at $6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CLVLY's P/E ratio is 13.91. In terms of profitability, BIORQ's ROE is +1.22%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, BIORQ is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check CLVLY's competition here
BIORQ vs SCNLF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, SCNLF has a market cap of 314.4M. Regarding current trading prices, BIORQ is priced at $0.00, while SCNLF trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SCNLF's P/E ratio is -30.30. In terms of profitability, BIORQ's ROE is +1.22%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, BIORQ is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check SCNLF's competition here
BIORQ vs NGENF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, BIORQ is priced at $0.00, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas NGENF's P/E ratio is -15.19. In terms of profitability, BIORQ's ROE is +1.22%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, BIORQ is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check NGENF's competition here
BIORQ vs FGHQF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, BIORQ is priced at $0.00, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, BIORQ and FGHQF have similar daily volatility (0.00).Check FGHQF's competition here
BIORQ vs PBBIF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, BIORQ is priced at $0.00, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, BIORQ's ROE is +1.22%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, BIORQ and PBBIF have similar daily volatility (0.00).Check PBBIF's competition here
BIORQ vs ORYZF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, ORYZF has a market cap of 286.8M. Regarding current trading prices, BIORQ is priced at $0.00, while ORYZF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ORYZF's P/E ratio is -123.33. In terms of profitability, BIORQ's ROE is +1.22%, compared to ORYZF's ROE of -0.02%. Regarding short-term risk, BIORQ is less volatile compared to ORYZF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check ORYZF's competition here
BIORQ vs ORPOF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, BIORQ is priced at $0.00, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, BIORQ's ROE is +1.22%, compared to ORPOF's ROE of N/A. Regarding short-term risk, BIORQ and ORPOF have similar daily volatility (0.00).Check ORPOF's competition here
BIORQ vs HNSBF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, BIORQ is priced at $0.00, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas HNSBF's P/E ratio is -3.41. In terms of profitability, BIORQ's ROE is +1.22%, compared to HNSBF's ROE of +2.02%. Regarding short-term risk, BIORQ is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check HNSBF's competition here
BIORQ vs CMVLF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, BIORQ is priced at $0.00, while CMVLF trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CMVLF's P/E ratio is -4.60. In terms of profitability, BIORQ's ROE is +1.22%, compared to CMVLF's ROE of -0.81%. Regarding short-term risk, BIORQ and CMVLF have similar daily volatility (0.00).Check CMVLF's competition here
BIORQ vs BOVNF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, BIORQ is priced at $0.00, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to BOVNF's ROE of -0.54%. Regarding short-term risk, BIORQ is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check BOVNF's competition here
BIORQ vs IPHYF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, IPHYF has a market cap of 211.3M. Regarding current trading prices, BIORQ is priced at $0.00, while IPHYF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas IPHYF's P/E ratio is -3.52. In terms of profitability, BIORQ's ROE is +1.22%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, BIORQ is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check IPHYF's competition here
BIORQ vs FPHAF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, BIORQ is priced at $0.00, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, BIORQ's ROE is +1.22%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, BIORQ and FPHAF have similar daily volatility (0.00).Check FPHAF's competition here
BIORQ vs PHCUF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, PHCUF has a market cap of 196.6M. Regarding current trading prices, BIORQ is priced at $0.00, while PHCUF trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas PHCUF's P/E ratio is 21.74. In terms of profitability, BIORQ's ROE is +1.22%, compared to PHCUF's ROE of +0.17%. Regarding short-term risk, BIORQ is less volatile compared to PHCUF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check PHCUF's competition here
BIORQ vs HLOSF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, HLOSF has a market cap of 193.8M. Regarding current trading prices, BIORQ is priced at $0.00, while HLOSF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas HLOSF's P/E ratio is -10.59. In terms of profitability, BIORQ's ROE is +1.22%, compared to HLOSF's ROE of -0.75%. Regarding short-term risk, BIORQ and HLOSF have similar daily volatility (0.00).Check HLOSF's competition here
BIORQ vs SPHRY Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, SPHRY has a market cap of 192.8M. Regarding current trading prices, BIORQ is priced at $0.00, while SPHRY trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SPHRY's P/E ratio is -76.33. In terms of profitability, BIORQ's ROE is +1.22%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, BIORQ and SPHRY have similar daily volatility (0.00).Check SPHRY's competition here
BIORQ vs SPHRF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, SPHRF has a market cap of 185.2M. Regarding current trading prices, BIORQ is priced at $0.00, while SPHRF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SPHRF's P/E ratio is -44.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, BIORQ is less volatile compared to SPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check SPHRF's competition here
BIORQ vs ADOCY Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, BIORQ is priced at $0.00, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, BIORQ's ROE is +1.22%, compared to ADOCY's ROE of +8.60%. Regarding short-term risk, BIORQ and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
BIORQ vs KNTPF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, KNTPF has a market cap of 164.4M. Regarding current trading prices, BIORQ is priced at $0.00, while KNTPF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas KNTPF's P/E ratio is -5.84. In terms of profitability, BIORQ's ROE is +1.22%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, BIORQ is less volatile compared to KNTPF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check KNTPF's competition here
BIORQ vs BBIXF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, BBIXF has a market cap of 151.8M. Regarding current trading prices, BIORQ is priced at $0.00, while BBIXF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BBIXF's P/E ratio is -13.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to BBIXF's ROE of -15.41%. Regarding short-term risk, BIORQ is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check BBIXF's competition here
BIORQ vs SLNCF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, SLNCF has a market cap of 150.2M. Regarding current trading prices, BIORQ is priced at $0.00, while SLNCF trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SLNCF's P/E ratio is -1.96. In terms of profitability, BIORQ's ROE is +1.22%, compared to SLNCF's ROE of -1.15%. Regarding short-term risk, BIORQ and SLNCF have similar daily volatility (0.00).Check SLNCF's competition here
BIORQ vs AMGXF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, BIORQ is priced at $0.00, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, BIORQ's ROE is +1.22%, compared to AMGXF's ROE of -0.71%. Regarding short-term risk, BIORQ is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check AMGXF's competition here
BIORQ vs HBPCF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, HBPCF has a market cap of 130.6M. Regarding current trading prices, BIORQ is priced at $0.00, while HBPCF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas HBPCF's P/E ratio is -42.75. In terms of profitability, BIORQ's ROE is +1.22%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, BIORQ and HBPCF have similar daily volatility (0.00).Check HBPCF's competition here
BIORQ vs AAPGV Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, BIORQ is priced at $0.00, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas AAPGV's P/E ratio is N/A. In terms of profitability, BIORQ's ROE is +1.22%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, BIORQ is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check AAPGV's competition here
BIORQ vs TRGNF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, TRGNF has a market cap of 122.6M. Regarding current trading prices, BIORQ is priced at $0.00, while TRGNF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas TRGNF's P/E ratio is -2.83. In terms of profitability, BIORQ's ROE is +1.22%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, BIORQ and TRGNF have similar daily volatility (0.00).Check TRGNF's competition here
BIORQ vs PSTTF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, BIORQ is priced at $0.00, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to PSTTF's ROE of N/A. Regarding short-term risk, BIORQ and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
BIORQ vs JWCTF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, JWCTF has a market cap of 116.7M. Regarding current trading prices, BIORQ is priced at $0.00, while JWCTF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas JWCTF's P/E ratio is -1.40. In terms of profitability, BIORQ's ROE is +1.22%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, BIORQ is less volatile compared to JWCTF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check JWCTF's competition here
BIORQ vs BRIBF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, BRIBF has a market cap of 112.1M. Regarding current trading prices, BIORQ is priced at $0.00, while BRIBF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BRIBF's P/E ratio is -3.11. In terms of profitability, BIORQ's ROE is +1.22%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, BIORQ is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check BRIBF's competition here
BIORQ vs EPRXF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, BIORQ is priced at $0.00, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, BIORQ's ROE is +1.22%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, BIORQ is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check EPRXF's competition here
BIORQ vs ADOIF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, BIORQ is priced at $0.00, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, BIORQ's ROE is +1.22%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, BIORQ and ADOIF have similar daily volatility (0.00).Check ADOIF's competition here
BIORQ vs MSCLF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, BIORQ is priced at $0.00, while MSCLF trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, BIORQ's ROE is +1.22%, compared to MSCLF's ROE of -0.70%. Regarding short-term risk, BIORQ is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check MSCLF's competition here
BIORQ vs MLLCF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, MLLCF has a market cap of 95.7M. Regarding current trading prices, BIORQ is priced at $0.00, while MLLCF trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas MLLCF's P/E ratio is -1.29. In terms of profitability, BIORQ's ROE is +1.22%, compared to MLLCF's ROE of -0.66%. Regarding short-term risk, BIORQ and MLLCF have similar daily volatility (0.00).Check MLLCF's competition here
BIORQ vs MCURF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, BIORQ is priced at $0.00, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas MCURF's P/E ratio is -16.90. In terms of profitability, BIORQ's ROE is +1.22%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, BIORQ is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check MCURF's competition here
BIORQ vs RECEF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, RECEF has a market cap of 80.4M. Regarding current trading prices, BIORQ is priced at $0.00, while RECEF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas RECEF's P/E ratio is -3.67. In terms of profitability, BIORQ's ROE is +1.22%, compared to RECEF's ROE of +2.79%. Regarding short-term risk, BIORQ is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check RECEF's competition here
BIORQ vs ETXPF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, ETXPF has a market cap of 76M. Regarding current trading prices, BIORQ is priced at $0.00, while ETXPF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ETXPF's P/E ratio is -6.50. In terms of profitability, BIORQ's ROE is +1.22%, compared to ETXPF's ROE of -0.51%. Regarding short-term risk, BIORQ and ETXPF have similar daily volatility (0.00).Check ETXPF's competition here
BIORQ vs PRRUF Comparison May 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 452. In comparison, PRRUF has a market cap of 73.7M. Regarding current trading prices, BIORQ is priced at $0.00, while PRRUF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas PRRUF's P/E ratio is -1.25. In terms of profitability, BIORQ's ROE is +1.22%, compared to PRRUF's ROE of -0.53%. Regarding short-term risk, BIORQ and PRRUF have similar daily volatility (0.00).Check PRRUF's competition here